COVID-19 Update
FROM: John Burns, President and CEO, and Will Blackwell, Vice President Health Services On March 29, 2022, the U.S. Food and Drug Administration (FDA) authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals. This includes individuals 50 years… Read More